The Secretome of Bone Marrow and Wharton Jelly Derived Mesenchymal Stem Cells Induces Differentiation and Neurite Outgrowth in SH-SY5Y Cells

Article English OPEN
Pires, Ana O.; Neves-Carvalho, Andreia; Sousa, Nuno; Salgado, António J.;
(2014)

The goal of this study was to determine and compare the effects of the secretome of mesenchymal stem cells (MSCs) isolated from human bone-marrow (BMSCs) and the Wharton jelly surrounding the vein and arteries of the umbilical cord (human umbilical cord perivascular cel... View more
  • References (53)
    53 references, page 1 of 6

    [1] J. G. Emsley, B. D. Mitchell, G. Kempermann, and J. D. Macklis, “Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells,” Progress in Neurobiology, vol. 75, no. 5, pp. 321-341, 2005.

    [2] M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for denfiing multipotent mesenchymal stromal cells. The International Society for Cellular eThrapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.

    [3] F. G. Teixeira, M. M. Carvalho, N. Sousa, and A. J. Salgado, “Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?” Cellular and Molecular Life Sciences, vol. 70, pp. 3871-3882, 2013.

    [4] M. M. Carvalho, F. G. Teixeira, R. L. Reis, N. Sousa, and A. J. Salgado, “Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine,” Current Stem Cell Research and eThrapy , vol. 6, no. 3, pp. 221-228, 2011.

    [5] H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., “Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inaflmmatory/immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638-14643, 2008.

    [6] A. C. Hirko, R. Dallasen, S. Jomura, and Y. Xu, “Modulation of inflammatory responses aeftr global ischemia by transplanted umbilical cord matrix stem cells,” Stem Cells, vol. 26, no. 11, pp. 2893-2901, 2008.

    [7] D. Cizkova, J. Rosocha, I. Vanicky, S. Jergova, and M. Cizek, “Transplants of human mesenchymal stem cells improve functional recovery aeftr spinal cord injury in the rat,” Cellular and Molecular Neurobiology, vol. 26, pp. 1167-1180, 2006.

    [8] H. L. Kyung, H. Suh-Kim, S. C. Ji et al., “Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats,” Acta Neurobiologiae Experimentalis, vol. 67, no. 1, pp. 13-22, 2007.

    [9] G. Bouchez, L. Sensebe´, P. Vourc'h et al., “Partial recovery of dopaminergic pathway aeftr graft of adult mesenchymal stem cells in a rat model of Parkinson's disease,” Neurochemistry International, vol. 52, no. 7, pp. 1332-1342, 2008.

    [10] M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., “Human umbilical cord matrix stem cells: preliminary characterization and eefct of transplantation in a rodent model of Parkinson's disease,” Stem Cells, vol. 24, no. 3, pp. 781-792, 2006.

  • Related Research Results (1)
  • Related Organizations (1)
  • Metrics
Share - Bookmark